Our research program aims to explore novel approaches for antiviral chemotherapy and immune intervention that build on recent developments in molecular virology and immunology. The individual research projects address antiviral small molecules (area A), immune cell-mediated antiviral effects (area B), and antibody-based approaches (area C). Altogether, we envision multimodal antiviral strategies that combine antiviral chemotherapy with immune-based interventions as the most promising path towards the control of persistent viruses. For more information on the available projects see https://www.virologie.uk-erlangen.de/en/grk2504/research-projects/